Technical Analysis for FARN - Faron Pharmaceuticals Oy
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| D | 355.0 | 2.90% | 10.00 |
FARN closed up 2.9 percent on Friday, April 16, 2021, on 63 percent of normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline. Its advance stalled at its 200 day moving average, an important long-term support / resistance line.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Flat | Up | Up |
| Historical FARN trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 200 DMA Resistance | Bearish | 0.00% | |
| 20 DMA Support | Bullish | 0.00% | |
| Crossed Above 50 DMA | Bullish | 0.00% | |
| Death Cross | Bearish | 2.90% | |
| 20 DMA Support | Bullish | 2.90% | |
| NR7 | Range Contraction | 2.90% | |
| Inside Day | Range Contraction | 2.90% | |
| 200 DMA Resistance | Bearish | 4.41% | |
| 50 DMA Resistance | Bearish | 4.41% | |
| 20 DMA Support | Bullish | 4.41% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time |
|---|---|
| No Alerts Yet. Alerts will only show here if at least one person is tracking alerts on this stock. | |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
Faron Pharmaceuticals Oy is a Finland-based biopharmaceutical company engaged in the biotechnology and medical research industry. The Company develops late stage clinical drugs focusing on acute organ traumas, cancer immunotherapy and vascular damage. Its product pipeline includes Traumakine (FP-1201-lyo), an Acute Respiratory Distress Syndrome (ARDS) treatment that is in phase Three development; and Clevegen (FP-1304), an anti-Clever-1 immunotheraphy tumor targeting candidate that is in pre-clinical stage development.
Sector: Healthcare
Industry: Biotechnology
Keywords: Target Research Pharmaceutical Biotechnology Medicine Clinic Pipe Pharmaceuticals Cancer Branches Of Biology Targeting Medical Specialties Drugs Therapy Biopharmaceutical Respirator Tumor Immunotherapy Medical Research
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Target Research Pharmaceutical Biotechnology Medicine Clinic Pipe Pharmaceuticals Cancer Branches Of Biology Targeting Medical Specialties Drugs Therapy Biopharmaceutical Respirator Tumor Immunotherapy Medical Research
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 530.0 |
| 52 Week Low | 216.0534 |
| Average Volume | 19,336 |
| 200-Day Moving Average | 355.43 |
| 50-Day Moving Average | 351.47 |
| 20-Day Moving Average | 342.47 |
| 10-Day Moving Average | 345.35 |
| Average True Range | 22.65 |
| ADX | 14.39 |
| +DI | 16.68 |
| -DI | 11.68 |
| Chandelier Exit (Long, 3 ATRs ) | 312.05 |
| Chandelier Exit (Short, 3 ATRs ) | 367.95 |
| Upper Bollinger Band | 363.82 |
| Lower Bollinger Band | 321.13 |
| Percent B (%b) | 0.79 |
| BandWidth | 12.46 |
| MACD Line | 1.77 |
| MACD Signal Line | 0.16 |
| MACD Histogram | 1.6059 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 385.00 | ||||
| Resistance 3 (R3) | 383.33 | 371.67 | 380.00 | ||
| Resistance 2 (R2) | 371.67 | 364.03 | 372.50 | 378.33 | |
| Resistance 1 (R1) | 363.33 | 359.31 | 367.50 | 365.00 | 376.67 |
| Pivot Point | 351.67 | 351.67 | 353.75 | 352.50 | 351.67 |
| Support 1 (S1) | 343.33 | 344.03 | 347.50 | 345.00 | 333.33 |
| Support 2 (S2) | 331.67 | 339.31 | 332.50 | 331.67 | |
| Support 3 (S3) | 323.33 | 331.67 | 330.00 | ||
| Support 4 (S4) | 325.00 |
